We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$245M
AUM Growth
+$31M
Cap. Flow
+$33M
Cap. Flow %
13.48%
Top 10 Hldgs %
7.31%
Holding
511
New
57
Increased
251
Reduced
151
Closed
49

Top Buys

Rank Stock Value
1
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$1.9M
2
COIN icon
Coinbase
COIN
+$1.35M
3
DOCU
DocuSign
DOCU
+$1.32M
4
SPOT icon
Spotify
SPOT
+$1.28M
5
UAL icon
United Airlines
UAL
+$1.28M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$1.14M
2
EXPE icon
Expedia Group
EXPE
+$1.04M
3
KKR icon
KKR & Co
KKR
+$976K
4
CME icon
CME Group
CME
+$974K
5
CPAY icon
Corpay
CPAY
+$948K

Sector Composition

Rank Sector Weight
1 Financials 29.48%
2 Technology 14.86%
3 Healthcare 14.81%
4 Industrials 11.61%
5 Consumer Discretionary 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
451
Altimmune
ALT
$568M
$59.7K 0.02%
+8,277
New +$63.2K
IMNM icon
452
Immunome
IMNM
$2.62B
$57.8K 0.02%
5,440
-303
-5% -$3.66K
FDMT icon
453
4D Molecular Therapeutics
FDMT
$502M
$57.6K 0.02%
10,333
+6,560
+174% +$51.5K
SANA icon
454
Sana Biotechnology
SANA
$882M
$56.8K 0.02%
34,849
+21,959
+170% +$65.5K
TSHA icon
455
Taysha Gene Therapies
TSHA
$1.61B
$54.7K 0.02%
31,597
+9,494
+43% +$19.7K
IGMS
456
DELISTED
IGM Biosciences
IGMS
$52.8K 0.02%
8,649
-2,957
-25% -$35.1K
BCYC
457
Bicycle Therapeutics
BCYC
$269M
$49.5K 0.02%
3,535
-254
-7% -$5.44K
CRVS icon
458
Corvus Pharmaceuticals
CRVS
$1.1B
$47.1K 0.02%
+8,799
New +$65.7K
SITC icon
459
SITE Centers
SITC
$236M
$45.9K 0.02%
3,003
-11,471
-79% -$185K
LRMR icon
460
Larimar Therapeutics
LRMR
$377M
$45K 0.02%
11,635
+2,127
+22% +$14K
SCLX icon
461
Scilex Holding
SCLX
$46.1M
$7.27K ﹤0.01%
513
– –
AAPL icon
462
Apple
AAPL
$4.97T
– –
-4,062
Closed -$946K
AGEN
463
Agenus
AGEN
$276M
– –
-5,759
Closed -$31.6K
AJG icon
464
Arthur J. Gallagher & Co
AJG
$69.1B
– –
-3,122
Closed -$878K
ALEC icon
465
Alector
ALEC
$169M
– –
-18,697
Closed -$87.1K
ALXO icon
466
ALX Oncology
ALXO
$262M
– –
-10,920
Closed -$19.9K
AME icon
467
Ametek
AME
$53.9B
– –
-5,140
Closed -$883K
APLT
468
DELISTED
Applied Therapeutics
APLT
– –
-17,524
Closed -$149K
JBIO
469
Jade Biosciences
JBIO
$1.18B
– –
-107
Closed -$7.83K
CABA icon
470
Cabaletta Bio
CABA
$427M
– –
-7,338
Closed -$34.6K
CDNS icon
471
Cadence Design Systems
CDNS
$91.6B
– –
-3,421
Closed -$927K
CME icon
472
CME Group
CME
$95.4B
– –
-4,415
Closed -$974K
COR icon
473
Cencora
COR
$62B
– –
-3,890
Closed -$876K
CPRT icon
474
Copart
CPRT
$28.5B
– –
-17,344
Closed -$909K
CTSH icon
475
Cognizant
CTSH
$25.2B
– –
-11,873
Closed -$916K
17 18
19
20 21

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Virtus ETF Advisers held 511 positions worth $245M, up 15% from $214M the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.

Virtus ETF Advisers deployed $33M of net new capital in Q4 2024, opening 57 new positions and adding to 251 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 19,660 shares worth $1.88M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $1.14M trimmed.

  • Virtus ETF Advisers's largest Q4 2024 buy was State Street SPDR Bloomberg High Yield Bond ETF: 19,660 shares worth $1.88M.
  • Virtus ETF Advisers added most to Eagle Point Credit Company in Q4 2024, an estimated $515K increase.
  • Virtus ETF Advisers's biggest Q4 2024 reduction was Applovin, cutting an estimated $1.14M.
  • Virtus ETF Advisers fully exited Expedia Group in Q4 2024, selling an estimated $1.04M.
  • Virtus ETF Advisers's ten largest holdings make up 7.3% of its $245M portfolio in Q4 2024.
  • Virtus ETF Advisers opened 57 new positions and closed 49 in Q4 2024.
  • Virtus ETF Advisers's portfolio value rose 15% quarter-over-quarter to $245M.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.